Малта - Енглески - Medicines Authority

baxter holding b.v. kobaltweg 49, 3542ce utrecht, netherlands - calcium chloride, dihydrate, phenylalanine, potassium chloride, histidine, arginine, aspartic acid, olive oil, threonine, tyrosine, valine, glucose monohydrate, glutamic acid, glycine, methionine, isoleucine, tryptophan, lysine, magnesium chloride, hexahydrate, serine, proline, sodium acetate, trihydrate, sodium glycerophosphate, soybean oil - emulsion for infusion - calcium chloride dihydrate phenylalanine potassium chloride histidine arginine aspartic acid olive oil threonine tyrosine valine glucose monohydrate glutamic acid glycine methionine isoleucine l-tryptophan lysine magnesium chloride hexahydrate serine proline sodium acetate trihydrate sodium glycerophosphate soybean oil - blood substitutes and perfusion solutions

Малта - Енглески - Medicines Authority

baxter holding b.v. kobaltweg 49, 3542ce utrecht, netherlands - calcium chloride, dihydrate, phenylalanine, potassium chloride, histidine, arginine, aspartic acid, olive oil, threonine, tyrosine, valine, glucose monohydrate, glutamic acid, glycine, methionine, isoleucine, tryptophan, lysine, magnesium chloride, hexahydrate, serine, proline, sodium acetate, trihydrate, sodium glycerophosphate, soybean oil - emulsion for infusion - calcium chloride dihydrate phenylalanine potassium chloride histidine arginine aspartic acid olive oil threonine tyrosine valine glucose monohydrate glutamic acid glycine methionine isoleucine l-tryptophan lysine magnesium chloride hexahydrate serine proline sodium acetate trihydrate sodium glycerophosphate soybean oil - blood substitutes and perfusion solutions

Малта - Енглески - Medicines Authority

baxter holding b.v. kobaltweg 49, 3542ce utrecht, netherlands - calcium chloride, dihydrate, phenylalanine, potassium chloride, histidine, arginine, aspartic acid, olive oil, threonine, tyrosine, valine, glucose monohydrate, glutamic acid, glycine, methionine, isoleucine, tryptophan, lysine, magnesium chloride, hexahydrate, serine, proline, sodium acetate, trihydrate, sodium glycerophosphate, soybean oil - emulsion for infusion - calcium chloride dihydrate phenylalanine potassium chloride histidine arginine aspartic acid olive oil threonine tyrosine valine glucose monohydrate glutamic acid glycine methionine isoleucine l-tryptophan lysine magnesium chloride hexahydrate serine proline sodium acetate trihydrate sodium glycerophosphate soybean oil - blood substitutes and perfusion solutions

Малта - Енглески - Medicines Authority

baxter holding b.v. kobaltweg 49, 3542ce utrecht, netherlands - calcium chloride, dihydrate, phenylalanine, histidine, arginine, threonine, tryptophan, tyrosine, valine, glycine, methionine, isoleucine, lysine hydrochloride, magnesium chloride, hexahydrate, serine, proline, sodium chloride, sodium lactate - solution for peritoneal dialysis - tryptophan 270 mg/l calcium chloride dihydrate 184 mg/l arginine 1071 mg/l alanine 951 mg/l phenylalanine 570 mg/l histidine 714 mg/l threonine 646 mg/l glycine 510 mg/l methionine 850 mg/l isoleucine 850 mg/l lysine hydrochloride 955 mg/l magnesium chloride hexahydrate 51 mg/l serine 510 mg/l leucine 1020 mg/l proline 595 mg/l sodium chloride 5380 mg/l sodium lactate 4480 mg/l tyrosine 300 mg/l valine 1393 mg/l - blood substitutes and perfusion solutions

Аустралија - Енглески - Department of Health (Therapeutic Goods Administration)

factors group australia pty ltd - tyrosine, quantity: 250 mg; withania somnifera, quantity: 150 mg (equivalent: withania somnifera, qty 1.5 g); bacopa monnieri, quantity: 25 mg (equivalent: bacopa monnieri, qty 4.75 g); zingiber officinale, quantity: 20 mg (equivalent: zingiber officinale, qty 500 mg); potassium iodide, quantity: 98.168 microgram (equivalent: iodine, qty 75 microgram); selenomethionine, quantity: 62.09 microgram (equivalent: selenium, qty 25 microgram); zinc sulfate monohydrate, quantity: 13.736 mg (equivalent: zinc, qty 5 mg); calcium pantothenate, quantity: 54.348 mg (equivalent: pantothenic acid, qty 50 mg); copper gluconate, quantity: 1.786 mg (equivalent: copper, qty 250 microgram); manganese sulfate monohydrate, quantity: 0.769 mg (equivalent: manganese, qty 250 microgram) - capsule, hard - excipient ingredients: microcrystalline cellulose; calcium hydrogen phosphate; calcium hydrogen phosphate dihydrate; oryza sativa; croscarmellose sodium; magnesium stearate; stearic acid; colloidal anhydrous silica; hypromellose - antioxidant/reduce free radicals formed in the body ; helps reduce/decrease free radical damage to body cells ; traditionally used in ayurvedic medicine to medhya/brain tonic/improve memory and cognition ; traditionally used in ayurvedic medicine to maintain/support energy levels ; traditionally used in ayurvedic medicine to relieve feelings of general malaise/general debility ; traditionally used in ayurvedic medicine to relieve weariness/tiredness/fatigue/feeling of weakness ; maintain/support healthy thyroid gland function ; maintain/support healthy thyroid hormones ; maintain/support thyroid gland health ; aid/assist thyroid hormone production ; maintain/support (state vitamin/mineral/nutrient) levels in the body ; traditionally used in ayurvedic medicine to adaptogen/help body adapt to stress ; traditionally used in ayurvedic medicine to enhance/promote body adaptation to stress ; enhance/promote body adaptation to stress ; support healthy stress response in the body ; traditionally used in ayurvedic medicine to support healthy stress response in the body ; decrease/reduce/relieve symptoms of stress ; traditionally used in ayurvedic medicine to maintain/support mental concentration/focus/clarity ; maintain/support cognitive function/mental function ; traditionally used in ayurvedic medicine to maintain/support cognitive function/mental function ; traditionally used in ayurvedic medicine to maintain/support memory/mental recall

Аустралија - Енглески - Department of Health (Therapeutic Goods Administration)

macro mike pty ltd - tyrosine, quantity: 80 mg/g; bacopa monnieri, quantity: 50 mg/g (equivalent: bacopa monnieri, qty 1 g/g); panax ginseng, quantity: 33.33 mg/g (equivalent: panax ginseng, qty 100 mg/g); ginkgo biloba, quantity: 24 mg/g (equivalent: ginkgo biloba, qty 1.2 g/g); pyridoxine hydrochloride, quantity: 753.6 microgram/g (equivalent: pyridoxine, qty 620 microgram/g); folic acid, quantity: 80 microgram/g; cyanocobalamin, quantity: 120 microgram/g - powder, oral - excipient ingredients: siraitia grosvenorii; stevia rebaudiana; vaccinium myrtillus; maltodextrin; hypromellose; colloidal anhydrous silica; glycine; citric acid; thaumatin; malic acid; flavour - traditionally used in ayurvedic medicine to medhya/brain tonic/improve memory and cognition ; maintain/support energy levels ; maintain/support energy production ; maintain/support physical endurance/capacity/stamina ; traditionally used in chinese medicine to relieve weariness/tiredness/fatigue/feeling of weakness ; traditionally used in chinese medicine to body tonic ; traditionally used in chinese medicine to maintain/support general health and wellbeing ; maintain/support general health and wellbeing ; maintain/support blood circulation/flow to the peripheral areas of the body (legs, hands and feet) ; maintain/support immune system health ; maintain/support healthy immune system function ; maintain/support mental concentration/focus/clarity ; maintain/support cognitive function/mental function ; maintain/support memory/mental recall ; aid/assist/helps synthesis of neurotransmitters ; maintain/support nervous system health ; maintain/support nervous system function

Аустралија - Енглески - Department of Health (Therapeutic Goods Administration)

integria healthcare australia pty ltd - tyrosine, quantity: 100 mg; soy phosphatidylserine-enriched soy lecithin powder, quantity: 142.86 mg (equivalent: soy phosphatidylserine, qty 100 mg); calcium pantothenate, quantity: 75 mg (equivalent: calcium, qty 6.29 mg; equivalent: pantothenic acid, qty 68.71 mg); pyridoxal 5-phosphate monohydrate, quantity: 25 mg (equivalent: pyridoxine, qty 15.95 mg); ornithine monohydrochloride, quantity: 255.07 mg (equivalent: ornithine, qty 200 mg) - tablet, film coated - excipient ingredients: iron oxide black; silicon dioxide; macrogol 400; calcium hydrogen phosphate dihydrate; carnauba wax; magnesium stearate; colloidal anhydrous silica; microcrystalline cellulose; crospovidone; chlorophyllin-copper complex; hypromellose; povidone; croscarmellose sodium - helps convert (state food) into energy ; maintain/support energy production ; maintain/support general health and wellbeing ; aid/assist healthy red blood cell production ; maintain/support red blood cell health ; maintain/support healthy thyroid gland function ; maintain/support healthy thyroid hormones ; maintain/support thyroid gland health ; aid/assist thyroid hormone production ; aid/assist/helps glucose/sugar/carbohydrate metabolism ; maintain/support (state vitamin/mineral/nutrient) levels in the body ; maintain/support (state vitamin/mineral) within normal range ; support healthy stress response in the body ; maintain/support neuroendocrine function ; aid/assist/helps synthesis of neurotransmitters ; support healthy emotional/mood balance

Аустралија - Енглески - Department of Health (Therapeutic Goods Administration)

integria healthcare australia pty ltd - tyrosine, quantity: 100 mg; ornithine monohydrochloride, quantity: 255.07 mg (equivalent: ornithine, qty 200 mg); calcium pantothenate, quantity: 75 mg (equivalent: pantothenic acid, qty 68.71 mg; equivalent: calcium, qty 6.29 mg); pyridoxal 5-phosphate monohydrate, quantity: 25 mg (equivalent: pyridoxine, qty 15.95 mg); soy phosphatidylserine-enriched soy lecithin powder, quantity: 141.43 mg (equivalent: soy phosphatidylserine, qty 100 mg) - tablet, film coated - excipient ingredients: colloidal anhydrous silica; crospovidone; chlorophyllin-copper complex; calcium hydrogen phosphate dihydrate; macrogol 400; microcrystalline cellulose; povidone; silicon dioxide; croscarmellose sodium; iron oxide black; hypromellose; carnauba wax; magnesium stearate - helps convert (state food) into energy ; maintain/support energy production ; maintain/support general health and wellbeing ; aid/assist healthy red blood cell production ; maintain/support red blood cell health ; maintain/support healthy thyroid gland function ; maintain/support healthy thyroid hormones ; maintain/support thyroid gland health ; aid/assist thyroid hormone production ; aid/assist/helps glucose/sugar/carbohydrate metabolism ; maintain/support (state vitamin/mineral/nutrient) levels in the body ; maintain/support (state vitamin/mineral) within normal range ; support healthy stress response in the body ; maintain/support neuroendocrine function ; aid/assist/helps synthesis of neurotransmitters ; support healthy emotional/mood balance

Аустралија - Енглески - Department of Health (Therapeutic Goods Administration)

bayer australia ltd - larotrectinib sulfate, quantity: 30.7 mg - capsule, hard - excipient ingredients: gelatin; propylene glycol; dimethicone 12500; brilliant blue fcf aluminium lake; titanium dioxide; shellac; strong ammonia solution - vitrakvi (larotrectinib) has provisional approval in australia for the treatment of adult and paediatric patients with locally advanced or metastatic solid tumours that:,? have a neurotrophic tyrosine receptor kinase (ntrk) gene fusion without a known acquired resistance mutation, ? are metastatic or where surgical resection is likely to result in severe morbidity, and ? have either progressed following treatment or who have no satisfactory alternative therapy. the decision to approve this indication has been made on the basis of objective response rate (orr) and duration of response from single arm clinical studies. the sponsor is required to submit further clinical data to confirm the clinical benefit of the medicine.

Аустралија - Енглески - Department of Health (Therapeutic Goods Administration)

bayer australia ltd - larotrectinib sulfate, quantity: 24.6 mg/ml - oral liquid, solution - excipient ingredients: sodium citrate dihydrate; hydroxypropylbetadex; purified water; flavour; sorbitol; methyl hydroxybenzoate; citric acid; sucrose; glycerol; monobasic sodium phosphate; potassium sorbate - vitrakvi (larotrectinib) has provisional approval in australia for the treatment of adult and paediatric patients with locally advanced or metastatic solid tumours that:,? have a neurotrophic tyrosine receptor kinase (ntrk) gene fusion without a known acquired resistance mutation, ? are metastatic or where surgical resection is likely to result in severe morbidity, and ? have either progressed following treatment or who have no satisfactory alternative therapy. the decision to approve this indication has been made on the basis of objective response rate (orr) and duration of response from single arm clinical studies. the sponsor is required to submit further clinical data to confirm the clinical benefit of the medicine.